Bayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer. by Alyssa Navarro
Healthy Living/Wellness Study Raises Safety Concern About Bayer Sterilization Device: Essure Tied With Increased Need For Reoperations by Julienne Roman
Healthy Living/Wellness Reports Of Health Complications Prompt FDA To Review Safety Of Essure Birth Control Implant by Julienne Roman
Healthy Living/Wellness Bayer Pushes Heart Failure Drug Finerenone To Final-Stage Trials by Rina Marie Doctor
Healthy Living/Wellness Court awards Chicago woman $14 mn in damages after taking wrongly prescribed Yasmin contraceptive by Rhodi Lee
Healthy Living/Wellness Prostate cancer drug Xofigo not recommended by British authorities due to cost effectiveness issues by Lori Sandoval
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband